Total Payments
$1,307
2024 Payments
$447.47
Companies
10
Transactions
50
Medicare Patients
4,004
Medicare Billing
$269,000
Payment Breakdown by Category
Food & Beverage$906.75 (69.4%)
Consulting$400.00 (30.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $906.75 | 49 | 69.4% |
| Consulting Fee | $400.00 | 1 | 30.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Cochlear Americas | $623.35 | 11 | $0 (2024) |
| MED-EL Corporation | $195.78 | 4 | $0 (2023) |
| ARBOR PHARMACEUTICALS, INC. | $142.80 | 13 | $0 (2018) |
| Supernus Pharmaceuticals, Inc. | $122.33 | 8 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $87.52 | 5 | $0 (2019) |
| Amgen Inc. | $42.70 | 2 | $0 (2019) |
| Mylan Specialty L.P. | $27.90 | 2 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $25.64 | 2 | $0 (2019) |
| Kaleo, Inc. | $23.55 | 1 | $0 (2017) |
| Advanced Bionics, LLC | $15.18 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $447.47 | 3 | Cochlear Americas ($447.47) |
| 2023 | $77.91 | 2 | Cochlear Americas ($47.30) |
| 2021 | $82.93 | 3 | MED-EL Corporation ($50.59) |
| 2020 | $38.94 | 3 | Supernus Pharmaceuticals, Inc. ($38.94) |
| 2019 | $272.68 | 11 | MED-EL Corporation ($114.58) |
| 2018 | $258.85 | 21 | ARBOR PHARMACEUTICALS, INC. ($122.95) |
| 2017 | $127.97 | 7 | Supernus Pharmaceuticals, Inc. ($40.25) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/02/2024 | Cochlear Americas | COCHLEAR NUCLEUS CI632 COCHLEAR IMPLANT WITH SLIM MODIOLAR ELECTRODE (Device), BAHA, OSIA OSI300 IMPLANT | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| Category: Implantable hearing solution | ||||||
| 06/25/2024 | Cochlear Americas | COCHLEAR NUCLEUS CI632 COCHLEAR IMPLANT WITH SLIM MODIOLAR ELECTRODE (Device), BAHA, OSIA OSI300 IMPLANT | Food and Beverage | Cash or cash equivalent | $41.68 | General |
| Category: Implantable hearing solution | ||||||
| 03/21/2024 | Cochlear Americas | COCHLEAR NUCLEUS CI632 COCHLEAR IMPLANT WITH SLIM MODIOLAR ELECTRODE (Device), BAHA, OSIA OSI300 IMPLANT | Food and Beverage | Cash or cash equivalent | $5.79 | General |
| Category: Implantable hearing solution | ||||||
| 11/10/2023 | Cochlear Americas | COCHLEAR NUCLEUS CI632 COCHLEAR IMPLANT WITH SLIM MODIOLAR ELECTRODE (Device), BAHA, OSIA OSI300 IMPLANT | Food and Beverage | Cash or cash equivalent | $47.30 | General |
| Category: Implantable hearing solution | ||||||
| 02/27/2023 | MED-EL Corporation | Mi1250 SYNCHRONY 2 FLEXsoft (Device), BCI 602 Kit | Food and Beverage | In-kind items and services | $30.61 | General |
| Category: Cochlear Implant | ||||||
| 10/04/2021 | MED-EL Corporation | MED-EL Maestro Cochlear Implant System (Device), VIBRANT Soundbridge Middle Ear Implant and BONEBRIDGE System, ADHEAR System | Food and Beverage | Cash or cash equivalent | $50.59 | General |
| Category: Cochlear Implant | ||||||
| 05/26/2021 | Cochlear Americas | Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode (Device), Baha BI300 implant 4 mm, Cochlear Osia OSI200 Implant | Food and Beverage | Cash or cash equivalent | $19.24 | General |
| Category: Implantable hearing solution | ||||||
| 03/31/2021 | Cochlear Americas | Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode (Device), Baha BI300 implant 4 mm, Cochlear Osia OSI200 Implant | Food and Beverage | Cash or cash equivalent | $13.10 | General |
| Category: Implantable hearing solution | ||||||
| 07/28/2020 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $14.21 | General |
| Category: AED | ||||||
| 05/19/2020 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $11.96 | General |
| Category: AED | ||||||
| 04/21/2020 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $12.77 | General |
| Category: AED | ||||||
| 11/18/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Central Nervous System | ||||||
| 10/05/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: Central Nervous System | ||||||
| 09/20/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Neuroscience | ||||||
| 08/23/2019 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2019 | MED-EL Corporation | VIBRANT Soundbridge Middle Ear Implant and BONEBRIDGE System (Device) | Food and Beverage | Cash or cash equivalent | $13.91 | General |
| Category: Active Implants | ||||||
| 07/19/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Neuroscience | ||||||
| 07/11/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $16.38 | General |
| Category: AED | ||||||
| 05/03/2019 | MED-EL Corporation | MED-EL Maestro Cochlear Implant System (Device) | Food and Beverage | Cash or cash equivalent | $100.67 | General |
| Category: Cochlear Implant | ||||||
| 03/11/2019 | Cochlear Americas | Nucleus (Device), Baha | Food and Beverage | Cash or cash equivalent | $29.73 | General |
| Category: Implantable hearing solution | ||||||
| 02/22/2019 | Cochlear Americas | Nucleus (Device), Baha | Food and Beverage | Cash or cash equivalent | $17.09 | General |
| Category: Implantable hearing solution | ||||||
| 01/31/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $10.93 | General |
| Category: AED | ||||||
| 12/11/2018 | Cochlear Americas | Nucleus (Device), Baha | Food and Beverage | Cash or cash equivalent | $18.11 | General |
| Category: Implantable hearing solution | ||||||
| 12/06/2018 | ARBOR PHARMACEUTICALS, INC. | Otovel (Drug) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: Pediatrics/Neonatology | ||||||
| 11/28/2018 | ARBOR PHARMACEUTICALS, INC. | Otovel (Drug) | Food and Beverage | In-kind items and services | $2.45 | General |
| Category: Pediatrics/Neonatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 226 | 274 | $70,866 | $19,421 |
| 2022 | 9 | 396 | 447 | $90,291 | $26,565 |
| 2021 | 19 | 878 | 1,033 | $148,104 | $58,174 |
| 2020 | 25 | 2,504 | 2,964 | $436,931 | $164,840 |
Total Patients
4,004
Total Services
4,718
Medicare Billing
$269,000
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 78 | $23,104 | $6,571 | 28.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 78 | 106 | $22,339 | $6,396 | 28.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $12,770 | $3,340 | 26.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 37 | 37 | $9,866 | $2,433 | 24.7% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 18 | 21 | $2,787 | $681.45 | 24.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 64 | 64 | $24,358 | $7,199 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 65 | 84 | $23,425 | $6,991 | 29.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 72 | 72 | $17,671 | $5,133 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 62 | 75 | $14,577 | $4,481 | 30.7% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 40 | 42 | $5,058 | $1,256 | 24.8% |
| 92557 | Comprehensive hearing and speech recognition test | Office | 2022 | 26 | 28 | $2,122 | $652.28 | 30.7% |
| 92504 | Exam of ear using a microscope | Office | 2022 | 30 | 43 | $2,105 | $545.75 | 25.9% |
| 92567 | Test to assess middle ear function | Office | 2022 | 25 | 27 | $867.00 | $278.78 | 32.2% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 12 | 12 | $108.00 | $28.80 | 26.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 166 | 205 | $37,425 | $16,816 | 44.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 210 | 230 | $25,816 | $12,932 | 50.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 87 | 87 | $25,505 | $9,814 | 38.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 38 | 38 | $7,855 | $2,681 | 34.1% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 69 | 74 | $7,158 | $2,211 | 30.9% |
| 92540 | Observation, testing, and recording of abnormal eye movement | Office | 2021 | 22 | 22 | $4,224 | $1,944 | 46.0% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2021 | 62 | 62 | $6,944 | $1,944 | 28.0% |
| 92584 | Testing of nerve from ear to brain (cochlear) | Office | 2021 | 19 | 19 | $3,686 | $1,806 | 49.0% |
| 92546 | Assessment and recording of abnormal eye movement with patient in a rotating chair | Office | 2021 | 17 | 17 | $3,162 | $1,604 | 50.7% |
| 92653 | Evaluation of brain response to sound for diagnosis of nervous system disorders with interpretation and report | Office | 2021 | 21 | 21 | $4,179 | $1,354 | 32.4% |
| 69220 | Removal of skin debris and drainage of mastoid cavity, simple | Office | 2021 | 19 | 21 | $3,916 | $1,048 | 26.8% |
About Dr. Brian Perry, M.D
Dr. Brian Perry, M.D is a Otology & Neurotology healthcare provider based in Mcallen, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619915832.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Perry, M.D has received a total of $1,307 in payments from pharmaceutical and medical device companies, with $447.47 received in 2024. These payments were reported across 50 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($906.75).
As a Medicare-enrolled provider, Perry has provided services to 4,004 Medicare beneficiaries, totaling 4,718 services with total Medicare billing of $269,000. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Otology & Neurotology
- Other Specialties Otolaryngology
- Location Mcallen, TX
- Active Since 06/02/2006
- Last Updated 07/12/2024
- Taxonomy Code 207YX0901X
- Entity Type Individual
- NPI Number 1619915832
Products in Payments
- COCHLEAR NUCLEUS CI632 COCHLEAR IMPLANT WITH SLIM MODIOLAR ELECTRODE (Device) $494.77
- MED-EL Maestro Cochlear Implant System (Device) $151.26
- Otovel (Drug) $142.80
- Nucleus (Device) $96.24
- TROKENDI XR (Drug) $82.08
- AIMOVIG (Biological) $51.83
- Aimovig (Biological) $42.70
- Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode (Device) $32.34
- Mi1250 SYNCHRONY 2 FLEXsoft (Device) $30.61
- Dymista (Drug) $27.90
- AJOVY (Drug) $25.64
- Auvi-Q (Drug) $23.55
- HiResolution Bionic Ear System (Device) $15.18
- VIBRANT Soundbridge Middle Ear Implant and BONEBRIDGE System (Device) $13.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.